SEARCH

SEARCH BY CITATION

References

  • Benowitz L., Rodriguez W., Paskevich P., Mufson E. J., Schenk D. and Neve R. L. (1989) The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer's disease subjects. Exp. Neurol. 106, 237250.
  • Benuck M., Banay-Schwartz M., DeGuzman T. and Lajtha A. (1996) Changes in brain protease activity in aging. J. Neurochem. 67, 20192029.
  • Breitner J. (2000) Epidemiologic clues to the causes and routes to prevention of Alzheimer disease. J. Neural Transm. 59, 251254.
  • Bridges K. (1987) Ascorbic acid inhibits lysosomal autophagy of ferritin. J. Biol. Chem. 262, 1477314778.
  • Cataldo A., Hamilton D., Barnett J., Paskevich P. and Nixon R. (1996) Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J. Neurosci. 16, 186199.
  • Chari S., Nath N. and Rathi A. (1983) In vitro effect of certain compounds on the lysosomal release of polymorphonuclear leukocytes. Ind. J. Physiol. Pharmacol. 27, 227233.
  • Chung H., Brazil M., Soe T. and Maxfield F. (1999) Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J. Biol. Chem. 274, 3230132308.
  • Cuervo A. and Dice J. (1996) A receptor for the selective uptake and degradation of proteins by lysosomes. Science 273, 501503.
  • Cuervo A. and Dice J. (1998) Lysosomes, a meeting point of proteins, chaperones, and proteases. J. Mol. Med. 76, 612.
  • Cuervo A. and Dice J. (2000) Regulation of lamp2a levels in the lysosomal membrane. Traffic 1, 570583.DOI: 10.1034/j.1600-0854.2000.010707.x
  • Cuervo A., Knecht E., Terlecky S. and Dice J. (1995) Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation. Am. J. Physiol. 269, C1200C1208.
  • Cuervo A., Dice J. and Knecht E. (1997) A lysosomal population responsible for the hsc73-mediated degradation of cytosolic proteins in lysosomes. J. Biol. Chem. 272, 56065615.
  • DeMartino G. and Slaughter C. (1999) The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274, 2212322126.
  • Dhariwal K., Hartzell W. and Levine M. (1991) Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum. Am. J. Clin. Nutr. 54, 712716.
  • Dice J. (2000) Lysosomal Pathways of Protein Degradation. Landes Bioscience, Austin, TX.
  • Foy C., Passmore A., Vahidassr M., Young I. and Lawson J. (1999) Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. Q. J. Medicine 92, 3945.
  • Freshney R. (1994) Culture of Animal Cells: a Manual of Basic Technique. Wiley-Liss, Inc, New York.
  • Grabarczyk M., Przybyszewski W., Kwiatkowska J., Sitarska E. and Malec J. (1983) Alteration in lysosome supravital staining as a marker of hydroxyurea-induced cytotoxicity and its modification by radical scavengers in L5178Y cells in culture. Neoplasma 30, 541545.
  • Grigor'ev I. P. (1988) Ultrastructural restructurings in the rat cerebral cortex after ascorbic acid administration into the ventricular cerebrospinal fluid. Arkh. Anat. Gistol. Embriol. 95, 2632.
  • Grunewald R. A. (1993) Ascorbic acid in the brain. Brain. Res. Rev. 18, 123133.
  • Gulve E. and Dice J. (1989) Regulation of protein synthesis and degradation in L8 myotubes. Effects of serum, insulin, and insulin-like growth factors. Biochem. J. 260, 377387.
  • Hoehn S. and Kanfer J. (1980) Effects of chronic ascorbic acid deficiency on guinea pig lysosomal hydrolase activities. J. Nutr. 110, 20852094.
  • Hoffman K., Yanelli K. and Bridges K. (1991) Ascorbic acid and iron metabolism: alterations in lysosomal function. Am. J. Clin. Nutr. 54, 1188S1192S.
  • Holen I., Strømhaug P., Gordon P., Fengsrud M., Berg T. and Seglen P. (1995) Inhibition of autophagy and multiple steps in asialoglycoprotein endocytosis by inhibitors of tyrosine protein kinases (tyrphostins). J. Biol. Chem. 270, 1282312831.
  • Imai K., Aimoto T., Sato M. and Kimura R. (1995) Resistance of hepatic lysosomes, mitochondria and microsomes of protoporphyrin-administered rats to peroxidative damage. Biol. Pharm. Bull. 18, 913916.
  • Jentoft N. and Dearborn D. (1983) Protein labeling by reductive alkylation. Methods Enzymol. 91, 570579.
  • Kiyatkin E. and Rebec G. (1998) Ascorbate modulates glutamate-induced excitation of striatal neurons. Brain Res. 812, 1422.
  • Kopito R. (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell. Biol. 10, 523530.
  • Laemmli U. (1970) Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227, 680685.
  • Leveille C. and Schwartz E. (1982) Effect of ascorbate on lysosomal enzyme activities in guinea pig cartilage and adrenals. Int. J. Vitam. Nutr. Res. 52, 436441.
  • Lowry O., Rosebrough N., Farr A. and Randall R. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265275.
  • Martin A. and Frei B. (1997) Both intracellular and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17, 15831590.
  • Martin A., Janigian D., Shukitt-Hale B., Prior R. and Joseph J. (1999) Effect of vitamin E intake on levels of vitamins E and C in the central nervous system and peripheral tissues: implications for health recommendations. Brain. Res. 845, 5059.
  • Masaki K., Losonczy K., Izmirlian G., Foley D., Ross G., Petrovitch H., Havlik R. and White L. (2000) Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 54, 12651272.
  • Murachi T. (1984) Calcium-dependent proteinases and specific inhibitors: calpain and calpastatin. Biochem. Soc. Symp. 49, 149167.
  • Nixon R., Saito K., Grynspan F., Griffin W., Katayama S., Honda T., Mohan P., Shea T. and Beermann M. (1994) Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann. N.Y. Acad. Sci. 747, 7791.
  • Ohkuma S., Moriyama Y. and Takano T. (1982) Identification and characterization of a proton pump on lysosomes by fluorescein-isothiocyanate-dextran fluorescence. Proc. Natl. Acad. Sci. 79, 27582762.
  • Ohsumi Y., Ishikawa T. and Kato K. (1983) A rapid and simplified method for the preparation of lysosomal membranes from rat liver. J. Biochem. 93, 547556.
  • Oke A., , L. M. and Adams R. (1987) Ascorbic acid distribution patterns in human brain. Ann. N.Y. Acad. Sci. 498, 112.
  • Paresce D., Chung H. and Maxfield F. (1996) Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells. J. Biol. Chem. 272, 2939029397.
  • Plotnikov M., Logvinov S., Pugachenko N., Maslov M., Aliev O., Tyukavina N., Suslov N. and Potapov A. (2000) Cerebroprotective effect of diquertin and ascorbic acid. Bull. Exp. Biol. Med. 130, 10801083.
  • Polidor M., Mecocci P. and Frei B. (2001) Plasma vitamin C levels are decreased and correlated with bain damage in patients with intracranial hemorrahge or head trauma. Stroke 32, 898902.
  • Rathi A., Nath N. and Chari S. (1984) Action of vitamin P like compounds on lysosomal fragility in hypercholesterolemia: implication of ascorbic acid and its metabolites. Acta Vitaminol. Enzymol. 6, 97102.
  • Rattan S. (1996) Synthesis, modifications, and turnover of proteins during aging. Exp. Gerontol. 31, 3347.
  • Rice M. (2000) Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 23, 209216.
  • Rice M. and Russo-Menna I. (1998) Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience 82, 12131223.
  • Rock K., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D. and Goldberg A. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761771.
  • Sapp E., Schwarz C., Chase K., Bhide P., Young A., Penney J., Vonsattel J., Aronin N. and DiFiglia M. (1997) Huntingtin localization in brains of normal and Huntington's disease patients. Ann. Neurol. 42, 604612.
  • Schneible P., Airhart J. and Low R. (1981) Differential compartmentation of leucine for oxidation and for protein synthesis in cultured skeletal muscle. J. Biol. Chem. 256, 48884894.
  • Seglen P., Gordon P. and Holen I. (1990) Nonselective autophagy. Semin. Cell. Biol. 1, 441448.
  • Sinclair A., Bayer A., Johnston J., Warner C. and Maxwell S. (1998) Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia. Int. J. Geriatric. Psych. 13, 840845.
  • Siushansian R., Tao L., Dixon S. J. and Wilson J. X. (1997) Cerebral astrocytes transport ascorbic acid and dehydroascorbic acid through distinct mechanisms regulated by cyclic AMP. J. Neurochem. 68, 23782385.
  • Storrie B. and Madden E. (1990) Isolation of subcellular organelles. Methods Enzymol. 182, 203225.
  • Svensson L., Wu C., Hulthe P., Johannessen K. and Enbel J. (1998) Effect of ageing on extracellular ascorbate concentration in rat brain. Brain Res. 609, 3640.
  • Towbin H., Staehelin T. and Gordon J. (1979) Electrophoretic transfer ofproteins from polyacrylamide to nitrocellulose sheets: procedureand some applications. Proc. Natl. Acad. Sci. 76, 43504354.
  • Waelter S., Boeddrich A., Lurz R., Scherzinger E., Lueder G., Lehrach H. and Wanker E. (2001) Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol. Biol. Cell 12, 13931407.
  • Wray W., Boulikas T., Wray V. and Hancock R. (1981) Silver staining of proteins in polyacrylamide gels. Anal. Biochem. 118, 197203.
  • Zdolsek J. and Svensson I. (1993) Effect of reactive oxygen species on lysosomal membrane integrity. A estudy on a lysosomal fraction. Virchows. Arch. B. Cell Pathol 64, 401406.